Seki K, Uesato T, Kato K, Shima K
Endocrinol Jpn. 1984 Dec;31(6):733-9. doi: 10.1507/endocrj1954.31.733.
The responses of the adenohypophyseal hormones to metoclopramide (MCP) were evaluated in hyperprolactinemic women with various radiological findings on the sella turcica. Serum PRL concentrations significantly increased after MCP administration in normal women, hyperprolactinemic patients with normal sella and patients with microadenoma, but not in macroadenoma patients with and without suprasellar expansion (SSE). The PRL response to MCP administration was significantly lower in hyperprolactinemic patients than in normal women. Serum TSH concentrations significantly increased after MCP administration in each group of subjects. The TSH response to MCP was significantly higher in patients with normal sella and patients with microadenoma than in normal women. However, the responses of PRL and TSH to MCP were not significantly different between patients with normal sella and patients with microadenoma. Therefore, they were not considered useful in distinguishing tumorous from nontumorous hyperprolactinemia. Serum LH concentrations significantly increased after MCP administration in patients with normal sella, patients with microadenoma and macroadenoma patients without SSE, but not in normal women or macroadenoma patients with SSE. The LH response to MCP was significantly higher in patients with microadenoma than in patients with normal sella. Serum FSH concentrations significantly increased after MCP administration only in patients with microadenoma. The different responses of the adenohypophyseal hormones to MCP in hyperprolactinemic women with various radiological findings on the sella turcica may be explained by the difference in the hypothalamic dopamine activity and in the impairment of the hypothalamic-pituitary system due to pituitary tumor.
对患有不同蝶鞍影像学表现的高催乳素血症女性,评估了腺垂体激素对甲氧氯普胺(MCP)的反应。正常女性、蝶鞍正常的高催乳素血症患者以及微腺瘤患者在给予MCP后血清催乳素(PRL)浓度显著升高,但有和无鞍上扩展(SSE)的大腺瘤患者则不然。高催乳素血症患者对MCP给药的PRL反应显著低于正常女性。每组受试者在给予MCP后血清促甲状腺激素(TSH)浓度均显著升高。蝶鞍正常的患者和微腺瘤患者对MCP的TSH反应显著高于正常女性。然而,蝶鞍正常的患者和微腺瘤患者对MCP的PRL和TSH反应无显著差异。因此,它们不被认为有助于区分肿瘤性和非肿瘤性高催乳素血症。蝶鞍正常的患者、微腺瘤患者以及无SSE的大腺瘤患者在给予MCP后血清促黄体生成素(LH)浓度显著升高,但正常女性或有SSE的大腺瘤患者则不然。微腺瘤患者对MCP的LH反应显著高于蝶鞍正常的患者。仅微腺瘤患者在给予MCP后血清促卵泡生成素(FSH)浓度显著升高。患有不同蝶鞍影像学表现的高催乳素血症女性对MCP的腺垂体激素反应不同,这可能是由于下丘脑多巴胺活性的差异以及垂体肿瘤导致的下丘脑 - 垂体系统损伤所致。